
Duramed Pharmaceuticals, Inc. ("Duramed"), respects your privacy, and the privacy of all visitors to its Web sites (the "Sites"). It is the company's policy to collect only personally identifiable information, such as names, addresses, telephone/fax numbers, or e-mail addresses, when such information is voluntarily submitted by our visitors. This information will be kept strictly confidential and will not be sold, reused, rented, loaned, or otherwise disclosed, except as described in this privacy policy. We will not disclose your information, other than to our contractors where necessary, to operate and maintain this Web site or as required by law or legal process. We will only use the information we collect from you to answer any of your requests for information, send you updates or other informational mailings you may find useful, or to better understand your needs.
Tracking Technology ("Cookies")
Cookies are small text files that are sent by a Web site, accepted by a Web browser and then placed on your hard drive. Duramed Web sites may use cookies to collect data that help provide information regarding the functionality of the site or to help analyze browsing patterns and use of the site.
Children
The Sites are not intended or designed to attract children under the age of 13. Duramed does not collect personally identifiable data from any person we know to be under the age of 13.
Revisions to This Policy
Duramed reserves the right, at our discretion, to change, modify, add, or remove portions of this Policy at any time. If we change our Privacy Policy, we will post those changes on this page so
that you may become aware of what information we may collect, how we may use it and under
what circumstances we may disclose it. You should visit this page from time to time to review the
current policy because it is binding on you. This Privacy Policy was last updated in November 2008.
General
Links from these Sites may take you to sites not covered by this Privacy Policy, and we advise
you to check the applicable privacy practices yourself.
©2009 Duramed Pharmaceuticals, Inc. All rights reserved.

ParaGard® does not protect against HIV/AIDS or other sexually transmitted infections. ParaGard® must not be used by women who are or may be pregnant; have acute pelvic inflammatory disease (PID) or current behavior suggesting a high risk for PID; have had a postpregnancy or postabortion uterine infection in the past 3 months; have cancer of the uterus or cervix; have an infection in the cervix; have an allergy to any component; or have Wilson's disease. The most common side effects of ParaGard® are heavier and longer periods and spotting between periods; for most women, these typically subside after 2 to 3 months. If a woman misses her period, she must be promptly evaluated for pregnancy. Some possible serious complications that have been associated with intrauterine contraceptives, including ParaGard®, are PID, perforation of the uterus, and expulsion.